SHIRE CANADA INC has a total of 49 patent applications. Its first patent ever was published in 1991. It filed its patents most often in Australia, EPO (European Patent Office) and Israel. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are BIOTA SCIENT MANAGEMENT, SHANDONG LUOXIN PHARMACEUTICAL GROUP STOCK CO LTD and PLUS CHEMICALS S A.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 6 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | Israel | 4 | |
#4 | Hong Kong | 3 | |
#5 | Honduras | 3 | |
#6 | Norway | 3 | |
#7 | South Africa | 3 | |
#8 | African Regional Industrial Property Organization | 2 | |
#9 | Canada | 2 | |
#10 | Republic of Korea | 2 | |
#11 | Mexico | 2 | |
#12 | New Zealand | 2 | |
#13 | Poland | 2 | |
#14 | United States | 2 | |
#15 | Brazil | 1 | |
#16 | China | 1 | |
#17 | Hungary | 1 | |
#18 | Japan | 1 | |
#19 | Malaysia | 1 | |
#20 | Nicaragua | 1 | |
#21 | Serbia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Sugars | |
#5 | Fermentation | |
#6 | Microorganisms | |
#7 | Special acyclic compounds | |
#8 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Simion Dan | 10 |
#2 | Cimpoia Alex | 9 |
#3 | Vizitiu Dragos | 8 |
#4 | Lacoste Jean-Eric | 7 |
#5 | Dan Simion | 4 |
#6 | Giles Francis J | 3 |
#7 | Alex Cimpoia | 3 |
#8 | Yu Qing | 3 |
#9 | Couch Richard A | 2 |
#10 | Michaels Alex | 2 |
Publication | Filing date | Title |
---|---|---|
JP2012136526A | METHOD FOR PRODUCING OPTICALLY ACTIVE cis-2-HYDROXYMETHYL-4-(CYTOSINE-1'-YL)-1,3-OXATHIOLANE OR PHARMACEUTICALLY PERMISSIBLE SALT THEREOF | |
NZ591709A | Enantiomeric resolution of 2,4-disubstituted 1,3-oxathiolane nucleosides by conglomerate resolution | |
MY146568A | Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1'-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof | |
ZA200707518B | Process and methods for the preparation of optically active cis-2-hydroxymethyl-4-(cytosin-1'-YL)-1,3-Oxathiolane or pharmaceutically acceptable salts thereof | |
AU2005329355A1 | Process and methods for the preparation of optically active cis-2-Hydroxymethyl-4-(cytosin-1'-yl)-1,3-oxathiolane or pharmaceutically acceptable salts | |
US2006199786A1 | Process and methods for the preparation of optically active cis-2-hydroxymethyl-4- (cytosin-1'-yl)-1,3-oxathiolane or pharmaceutically acceptable salts thereof | |
AU2002344862B2 | Stereoselective method for the preparation of nucleoside analogues |